Post-transcriptional gene silencing of ribosomal protein S6 kinase 1 restores insulin action in leucine-treated skeletal muscle

[1]  Pengxiang She,et al.  Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.

[2]  M. Watford,et al.  Leucing weight with a futile cycle. , 2007, Cell metabolism.

[3]  Yu Li,et al.  Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[4]  G. Thomas,et al.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.

[5]  L. Rui,et al.  A link between protein translation and body weight. , 2007, The Journal of clinical investigation.

[6]  F. Lönnqvist,et al.  Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. , 2006, Molecular endocrinology.

[7]  G. Thomas,et al.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.

[8]  O. Meyuhas,et al.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.

[9]  M. Pende.  mTOR, Akt, S6 kinases and the control of skeletal muscle growth. , 2006, Bulletin du cancer.

[10]  M. Krebs.  Amino acid‐dependent modulation of glucose metabolism in humans , 2005, European journal of clinical investigation.

[11]  A. Marette,et al.  Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. , 2005, Endocrinology.

[12]  J. Lawrence,et al.  Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in β-Cells* , 2005, Journal of Biological Chemistry.

[13]  B. Manning.  Balancing Akt with S6K , 2004, The Journal of cell biology.

[14]  M. Birnbaum,et al.  Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101* , 2004, Journal of Biological Chemistry.

[15]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[16]  J. Manson,et al.  A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. , 2004, Diabetes care.

[17]  Cristina M Rondinone,et al.  Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. , 2004, Biochemical and biophysical research communications.

[18]  P. Wretenberg,et al.  Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation. , 2004, Acta physiologica Scandinavica.

[19]  M. Nakayama,et al.  Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. , 2003, Biochemical and biophysical research communications.

[20]  G. Cooney,et al.  The role of intramuscular lipid in insulin resistance. , 2003, Acta physiologica Scandinavica.

[21]  A. Krook,et al.  RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. , 2003, Biochemical and biophysical research communications.

[22]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[23]  J. Zierath,et al.  Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content , 2003, Cellular and Molecular Life Sciences CMLS.

[24]  Peter Nowotny,et al.  Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. , 2002, Diabetes.

[25]  Y. Zick.  Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. , 2001, Trends in cell biology.

[26]  A. Marette,et al.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.

[27]  S. Kimball,et al.  Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. , 2001, The Journal of nutrition.

[28]  S. Bonavaud,et al.  Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells* , 2001, The Journal of Biological Chemistry.

[29]  R. Burcelin,et al.  Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.

[30]  J. Zierath,et al.  Insulin action and insulin resistance in human skeletal muscle , 2000, Diabetologia.

[31]  K. Kishi,et al.  Overexpression of wild-type Akt1 promoted insulin-stimulated p70S6 kinase (p70S6K) activity and affected GSK3 beta regulation, but did not promote insulin-stimulated GLUT4 translocation or glucose transport in L6 myotubes. , 2000, The journal of medical investigation : JMI.

[32]  S. Kimball,et al.  Amino acid-induced stimulation of translation initiation in rat skeletal muscle. , 1999, American journal of physiology. Endocrinology and metabolism.

[33]  M. Patti.  Nutrient Modulation of Cellular Insulin Action , 1999, Annals of the New York Academy of Sciences.

[34]  L. Shantz,et al.  Leucine Regulates Translation of Specific mRNAs in L6 Myoblasts through mTOR-mediated Changes in Availability of eIF4E and Phosphorylation of Ribosomal Protein S6* , 1999, The Journal of Biological Chemistry.

[35]  J. Zierath,et al.  Insulin-Stimulated Akt Kinase Activity Is Reduced in Skeletal Muscle From NIDDM Subjects , 1998, Diabetes.

[36]  J. Avruch,et al.  Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism* , 1998, The Journal of Biological Chemistry.

[37]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[38]  R. Geyer,et al.  Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[39]  P. Flakoll,et al.  Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability , 1992, Diabetologia.

[40]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[41]  J. Hofsteenge,et al.  Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide. , 1988, The Journal of biological chemistry.

[42]  M. Haymond,et al.  Decreased Uptake of Glucose by Human Forearm During Infusion of Leucine, Isoleucine, or Threonine , 1987, Diabetes.

[43]  L. Jefferson,et al.  Influence of amino acid availability on protein turnover in perfused skeletal muscle. , 1978, Biochimica et biophysica acta.

[44]  M. Buse,et al.  Leucine. A possible regulator of protein turnover in muscle. , 1975, The Journal of clinical investigation.

[45]  P. Felig,et al.  Plasma amino acid levels and insulin secretion in obesity. , 1969, The New England journal of medicine.

[46]  G. Freund,et al.  Leucine reduces the duration of insulin-induced PI 3-kinase activity in rat skeletal muscle. , 2005, American journal of physiology. Endocrinology and metabolism.

[47]  J. Lawrence,et al.  Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. , 2005, The Journal of biological chemistry.

[48]  C. Proud,et al.  Role of mTOR signalling in the control of translation initiation and elongation by nutrients. , 2004, Current topics in microbiology and immunology.

[49]  P. Pisters,et al.  The effects of euglycemic hyperinsulinemia and amino acid infusion on regional and whole body glucose disposal in man. , 1991, Metabolism: clinical and experimental.

[50]  P. Felig.  Amino acid metabolism in man. , 1975, Annual review of biochemistry.